Ultragenyx Pharmaceutical Inc. <RARE.O>: Leerink Partners cuts target price to $33 from $60
RARE•Related News
McDonald's <MCD.N>: Jefferies cuts target price to $325 from $350
MCD•
Gold holds steady as investors await Fed policy cues
GLD•
Trump says hit that brake; no, not that one
SPY•
Experts urge FDA to set clear safety and access standards for psychedelic drugs
XBI•
Visteon Corporation <VC.O>: JP Morgan cuts target price to $145 from $170
VC•